It's now six weeks since I finished my third round of Alemtuzumab, the disease modifying drug I opte...

Read my thoughts on disability inclusion in the workplace
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.